HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aspen Pharmacare Holdings Ltd.

www.aspenpharma.com

Latest From Aspen Pharmacare Holdings Ltd.

Lupin Offloads Kyowa For $525m But Not Exiting Japan

Lupin plans to invest in acquisitions and organic growth in the US and India after selling Japanese subsidiary Kyowa Pharma for an enterprise value of around $525m to Japan private equity group Unison Capital. But the Indian firm stresses it is not exiting Japan and will continue to look for marketing partnerships.

Deals Strategy

Lupin Offloads Kyowa Pharma For $525m But Not Exiting Japan

Lupin plans to invest in acquisitions and organic growth in the US and India after selling Japanese subsidiary Kyowa Pharma for an enterprise value of around $525m to Japan private equity group Unison Capital. But the Indian firm stresses it is not exiting Japan and will continue to look for marketing partnerships.

Deals India

Sandoz To Acquire Aspen’s Japanese Operations

Sandoz is to pay up to €400m for Aspen’s anesthetics and other specialty off-patent brands in Japan, strengthening the Novartis division’s local position in the hospitals market.

Japan M & A

Laurus Buys Way Into South African ARV Tenders

India’s Laurus Labs is aiming to supply antiretrovirals through South Africa’s public tender system after agreeing a deal to buy Aspen Pharmacare’s Phekolong Pharmaceuticals subsidiary.

Deals South Africa
See All

Company Information

UsernamePublicRestriction

Register